The effect of tamoxifen therapy on the endometrium and ovarian cyst formation in patients with breast cancer
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective To evaluate the effect of tamoxifen on female reproductive organs in women with breast cancer. Methods We retrospectively reviewed the medical records of 309 women with breast cancer who were currently receivingtamoxifen and undergoing regular gynecological examination. Results We evaluated 92 pre- and 217 postmenopausal women. The prevalence of endometrial thickening was 12%in the pre- and 10.6% in the postmenopausal group. An endometrial biopsy was performed in 43 women andconfirmed endometrial cancer in 1, endometrial polyps in 14, and endometrial hyperplasia in 4 women. Transvaginalultrasonography showed 25 cases of newly developed ovarian cysts. Most ovarian cysts had disappeared duringfollow-up. Conclusion Tamoxifen use in women with breast cancer causes few complications and is considered safe for female reproductiveorgans in case of regular gynecological examination.
Abstract
Objective To evaluate the effect of tamoxifen on female reproductive organs in women with breast cancer. Methods We retrospectively reviewed the medical records of 309 women with breast cancer who were currently receivingtamoxifen and undergoing regular gynecological examination. Results We evaluated 92 pre- and 217 postmenopausal women. The prevalence of endometrial thickening was 12%in the pre- and 10.6% in the postmenopausal group. An endometrial biopsy was performed in 43 women andconfirmed endometrial cancer in 1, endometrial polyps in 14, and endometrial hyperplasia in 4 women. Transvaginalultrasonography showed 25 cases of newly developed ovarian cysts. Most ovarian cysts had disappeared duringfollow-up. Conclusion Tamoxifen use in women with breast cancer causes few complications and is considered safe for female reproductiveorgans in case of regular gynecological examination.
참고문헌 (19)
- 김영애, "The Economic Burden of Breast Cancer in Korea from 2007-2010", Cancer Research and Treatment, 47(4), pp.583~590 (2015), 대한암학회[DOI]
- American Cancer Society, "Breast cancer facts & figures 2017-2018", American Cancer Society, ~ (2017)
- Murphy GP, "American Cancer Society textbook of clinical oncology" (1995), American Cancer Society
- Figg WD 2nd, "Aromatase inhibitor plus ovarian suppression as adjuvant therapy in premenopausal women with breast cancer", Cancer Biol Ther, 15, pp.1586~1587 (2014)[DOI]
- Le Donne M, "Endometrial pathology in breast cancer patients: effect of different treatments on ultrasonographic, hysteroscopic and histological findings", Oncol Lett, 5, pp.1305~1310 (2013)[DOI]
- Metindir J, "Ovarian cyst formation in patients using tamoxifen for breast cancer", Jpn J Clin Oncol, 35, pp.607~611 (2005)[DOI]
- Cheng WF, "Comparison of endometrial changes among symptomatic tamoxifentreated and nontreated premenopausal and postmenopausal breast cancer patients", Gynecol Oncol, 66, pp.233~237 (1997)[DOI]
- Cohen I, "Time-dependent effect of tamoxifen therapy on endometrial pathology in asymptomatic postmenopausal breast cancer patients", Int J Gynecol Pathol, 15, pp.152~157 (1996)[DOI]
- Sismondi P, "Tamoxifen and endometrial cancer", Ann N Y Acad Sci, 734, pp.310~321 (1994)[DOI]
- Ramondetta LM, "Endometrial cancer in polyps associated with tamoxifen use", Am J Obstet Gynecol, 180, pp.340~341 (1999)[DOI]
- Cohen I, "Ovarian tumors in postmenopausal breast cancer patients treated with tamoxifen", Gynecol Oncol, 60, pp.54~58 (1996)[DOI]
- Seoud MA, "Gynecologic tumors in tamoxifen-treated women with breast cancer", Obstet Gynecol, 82, pp.165~169 (1993)
- Gerber B, "Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound", J Clin Oncol, 18, pp.3464~3470 (2000)[DOI]
- Cohen I, "Significance of secondary ultrasonographic endometrial thickening in postmenopausal tamoxifen-treated women", Cancer, 94, pp.3101~3106 (2002)[DOI]
- 김호성, "The effect of adjuvant hormonal therapy on the endometrium and ovary of breast cancer patients", Journal of Gynecologic Oncology, 19(4), pp.256~260 (2008), 대한부인종양학회
- Cohen I, "Endometrial pathologies associated with postmenopausal tamoxifen treatment", Gynecol Oncol, 94, pp.256~266 (2004)[DOI]
- Deligdisch L, "Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer", Gynecol Oncol, 78, pp.181~186 (2000)[DOI]
- Jolles CJ, "Cystic ovarian necrosis complicating tamoxifen therapy for breast cancer in a premenopausal woman. A case report", J Reprod Med, 35, pp.299~300 (1990)
- Sherman BM, "Endocrine consequences of continuous antiestrogen therapy with tamoxifen in premenopausal women", J Clin Invest, 64, pp.398~404 (1979)[DOI]